BlackRock Investment Management’s Atossa Therapeutics ATOS Stock Holding History

BlackRock Investment Management’s Portfolio ATOS Stock Details ATOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1	Closed	-$1K	–	4038
2016 Q1	$1K	Hold	1	–	–	﹤0.01%	4009
2015 Q4	$1K	Hold	1	–	–	﹤0.01%	4049
2015 Q3	$3K	Hold	1	–	–	﹤0.01%	4023
2015 Q2	$4K	Hold	1	–	–	﹤0.01%	3988
2015 Q1	$5K	Hold	1	–	–	﹤0.01%	3849
2014 Q4	$4K	Hold	1	–	–	﹤0.01%	3955
2014 Q3	$4K	Hold	1	–	–	﹤0.01%	3934
2014 Q2	$5K	Buy	+1	New	+$3.89K	﹤0.01%	3866

Other funds holding ATOS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GBBWRPM

Genovese Burford & Brothers Wealth & Retirement Plan Management Sacramento, California $400M AUM 14.87% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BlackRock Investment Management's ATOS Position: Q2 2016 in Review

BlackRock Investment Management sold out of Atossa Therapeutics (ATOS) in Q2 2016, closing a stake of 1 share — an estimated $1K sold.

BlackRock Investment Management first reported a position in ATOS in Q2 2014 and held it in 8 quarters. The position peaked at $5K in Q1 2015. 14 funds tracked by Wall St. Rank hold ATOS as of Q2 2016.

BlackRock Investment Management reported no remaining Atossa Therapeutics position as of Q2 2016 after selling out during the quarter.
BlackRock Investment Management sold 1 Atossa Therapeutics share in Q2 2016, an estimated $1K.
BlackRock Investment Management first reported a position in Atossa Therapeutics in Q2 2014 and held it in 8 quarters.
BlackRock Investment Management's Atossa Therapeutics position peaked at $5K in Q1 2015.
14 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.